Biologia vascular hepàtica
                
            Publicacions destacades
- 
                                In vitro models for the study of liver biology and diseases - advances and limitationsKaur, S; Kidambi, S; Ortega-Ribera, M; Thuy, LT; Nieto, N;Cogger, VC; Xie, WF; Tacke, F; Gracia-Sancho, J.Referència:Cmgh Cellular And Molecular Gastroenterology And Hepatology 2023. 
- 
                                Review article: vascular effects of PPARs in the context of NASHGuixé-Muntet, S; Biquard, L; Szabo, G; Dufour, JF; Tacke, F;Francque, S; Rautou, PE; Gracia-Sancho, J.Referència:Alimentary Pharmacology & Therapeutics 2022. 
- 
                                Transcriptomic profiling of the liver sinusoidal endothelium during cirrhosis reveals stage-specific secretory signatureManicardi, Nicolo; Fernandez-Iglesias, Anabel; Abad-Jorda, Laia; Royo, Felix; Azkargorta, Mikel;(...)Cubero, Francisco Javier; Albillos, Agustin; Vaquero, Javier; Falcon-Perez, Juan M; Gracia-Sancho, Jordi.Referència:Cancers 2021. 
- 
                                Role of liver sinusoidal endothelial cells in liver diseasesGracia-Sancho, Jordi; Caparros, Esther; Fernandez-Iglesias, Anabel; Frances, Ruben;Referència:Nature Reviews Gastroenterology & Hepatology 2021. 
- 
                                Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver diseaseBoyer-Diaz, Zoe; Aristu-Zabalza, Peio; Andres-Rozas, Maria; Robert, Claude; Ortega-Ribera, Marti;(...)Broqua, Pierre; Junien, Jean-Louis; Wettstein, Guillaume; Bosch, Jaime; Gracia-Sancho, Jordi.Referència:Journal Of Hepatology 2021. 
- 
                                Regression of portal hypertension: underlying mechanisms and therapeutic strategiesSelicean, S; Wang, C; Guixé-Muntet, S; Gracia-Sancho, J; Stefanescu, H;Kawada, N.Referència:Hepatology International 2021. 
- 
                                Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosisGarcia Garcia de Paredes A; Villanueva C; Blanco C; Genescà J; Manicardi N;(...)Falcon-Perez JM; Bañares R; Bosch J; Gracia-Sancho J; Albillos A .Referència:Jhep Rep 2021. 
- 
                                Novel therapeutics for portal hypertension and fibrosis in chronic liver diseaseGuixe-Muntet, Sergi; Zhu, Chang-Peng; Xie, Wei-Fen; Gracia-Sancho, Jordi;Referència:Pharmacology & Therapeutics 2020. 
- 
                                Human amniotic stem cells improve hepatic microvascular dysfunction and portal hypertension in cirrhotic ratsPietrosi, Giada; Fernandez-Iglesias, Anabel; Pampalone, Mariangela; Ortega-Ribera, Marti; Lozano, Juan J;(...)Parolini, Ornella; Vizzini, Giovanni; Luca, Angelo; Bosch, Jaime; Gracia-Sancho, Jordi.Referència:Liver International 2020. 
- 
                                Ischemia/reperfusion injury in the aged liver: The importance of the sinusoidal endothelium in developing therapeutic strategies for the elderlyHide, D; Fernández-Iglesias, A; Maeso-Díaz, R; Bosch, J; Gracia-Sancho, J;Peralta, C; Warren, A; Le Couteur, DG; Cogger, VC.Referència:Journals Of Gerontology Series A-Biological Sciences And Medical Sciences 2020. 
